Juan Su Selected Research

Juan Su Research Topics

Disease

59	Neoplasms (Cancer) 06/2024 - 10/2007
48	Melanoma (Melanoma, Malignant) 05/2024 - 12/2006
26	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2024 - 12/2011
23	Neoplasm Metastasis (Metastasis) 04/2024 - 12/2006
11	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2024 - 11/2008
8	Chronic Urticaria 02/2024 - 12/2014
7	Skin Diseases (Skin Disease) 05/2024 - 01/2020
7	Infections 02/2024 - 01/2013
7	Breast Neoplasms (Breast Cancer) 11/2023 - 09/2013
7	Inflammation (Inflammations) 10/2023 - 09/2008
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2024 - 01/2021
6	Warts (Wart) 03/2022 - 05/2016
6	Hypoxia (Hypoxemia) 04/2021 - 05/2009
6	Carcinogenesis 01/2020 - 04/2016
5	Atopic Dermatitis (Atopic Eczema) 05/2024 - 07/2012
5	Acne Vulgaris 05/2024 - 01/2019
4	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 01/2022
4	Basal Cell Carcinoma (Rodent Ulcer) 05/2024 - 01/2021
4	Urticaria (Hives) 02/2024 - 03/2015
4	COVID-19 01/2023 - 07/2020
3	Pathologic Constriction (Stenosis) 02/2024 - 06/2023
3	Human Influenza (Influenza) 01/2024 - 01/2020
3	Skin Neoplasms (Skin Cancer) 03/2022 - 04/2019
2	Lung Neoplasms (Lung Cancer) 06/2024 - 01/2020
2	Cicatrix (Scar) 05/2024 - 03/2023
2	Crohn Disease (Crohn's Disease) 04/2024 - 08/2023
2	Fatigue 08/2023 - 06/2023
2	Cognitive Dysfunction 05/2023 - 01/2022
2	Thyroid Neoplasms (Thyroid Cancer) 03/2023 - 01/2015
2	Pain (Aches) 03/2023 - 10/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 06/2019
2	Hemolysis 01/2023 - 07/2022
2	Pre-Eclampsia (Preeclampsia) 01/2023 - 01/2022
2	Brain Neoplasms (Brain Tumor) 10/2022 - 10/2021
2	Glioma (Gliomas) 10/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2007
12	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2014
10	MicroRNAs (MicroRNA)IBA 06/2023 - 04/2012
9	Messenger RNA (mRNA)IBA 06/2023 - 05/2009
9	Small Interfering RNA (siRNA)IBA 04/2016 - 12/2006
8	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2020 - 01/2009
7	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2024 - 06/2019
7	EnzymesIBA 10/2023 - 11/2011
7	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 12/2006
6	Histamine Antagonists (Antihistamines)IBA 02/2024 - 03/2015
6	Therapeutic UsesIBA 01/2024 - 06/2014
5	Immune Checkpoint InhibitorsIBA 06/2024 - 01/2020
5	TNF Receptor-Associated Factor 6 (TRAF6)IBA 08/2023 - 02/2016
5	Acitretin FDA Link 01/2021 - 08/2016
5	Glycoproteins (Glycoprotein)IBA 01/2020 - 11/2008
4	ErbB Receptors (EGF Receptor)IBA 04/2024 - 09/2021
4	CytokinesIBA 12/2023 - 11/2020
4	ImmunosorbentsIBA 10/2023 - 03/2018
4	Polysaccharides (Glycans)IBA 08/2023 - 06/2016
4	Imiquimod (Aldara)FDA LinkGeneric 07/2023 - 01/2017
4	RNA (Ribonucleic Acid)IBA 01/2023 - 12/2006
4	CateninsIBA 01/2022 - 04/2012
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2017 - 12/2006
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 06/2010
3	LipidsIBA 01/2023 - 10/2017
3	Indicators and Reagents (Reagents)IBA 11/2022 - 01/2015
3	LigandsIBA 06/2022 - 10/2013
3	UbiquitinIBA 01/2022 - 01/2020
3	Lactic Acid (Lactate)FDA LinkGeneric 04/2021 - 01/2009
3	RetinoidsIBA 01/2021 - 01/2017
3	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 06/2013
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2017 - 04/2016
3	Cadherins (E-Cadherin)IBA 01/2015 - 01/2009
2	Antiviral Agents (Antivirals)IBA 01/2024 - 01/2017
2	Epidermal Growth Factor (EGF)IBA 11/2023 - 01/2022
2	Tyrosine Kinase InhibitorsIBA 11/2023 - 01/2018
2	ElementsIBA 08/2023 - 06/2023
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 07/2023 - 10/2017
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2023 - 06/2016
2	Formaldehyde (Formol)FDA Link 05/2023 - 01/2022
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 05/2023 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2023 - 01/2021
2	ArsenicIBA 01/2023 - 10/2017
2	LuciferasesIBA 01/2023 - 11/2020
2	Peptides (Polypeptides)IBA 01/2023 - 01/2017
2	Long Noncoding RNAIBA 01/2023 - 01/2013
2	3' Untranslated Regions (3' UTR)IBA 10/2022 - 12/2011
2	ChemokinesIBA 08/2022 - 09/2021
2	Monoclonal AntibodiesIBA 06/2022 - 01/2021
2	polypeptide 3 90kDa ribosomal protein S6 kinaseIBA 01/2022 - 10/2019
2	Deubiquitinating EnzymesIBA 01/2022 - 10/2021
2	CalciumIBA 01/2022 - 10/2013
2	Neutralizing AntibodiesIBA 12/2021 - 12/2020

Therapy/Procedure

36	Therapeutics 05/2024 - 08/2008
15	Photochemotherapy (Photodynamic Therapy) 05/2024 - 06/2019
8	Immunotherapy 01/2023 - 01/2020
6	Radiotherapy 10/2021 - 01/2014
5	Drug Therapy (Chemotherapy) 01/2020 - 09/2013
4	Aftercare (After-Treatment) 02/2024 - 01/2017
4	Stents 02/2024 - 06/2023
3	Length of Stay 01/2023 - 05/2014
3	Precision Medicine 10/2022 - 01/2019
2	Mohs Surgery (Mohs' Micrographic Surgery) 03/2024 - 12/2023
2	Cryotherapy (Therapy, Cold) 03/2022 - 10/2020
2	Lasers (Laser) 11/2021 - 12/2018